Status: current, Defined. Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3977538018 | Live attenuated Human alphaherpesvirus 3 vaccination via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977539014 | Live attenuated Varicella-zoster immunization via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977540011 | Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977541010 | Live attenuated Human alphaherpesvirus 3 immunisation via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977542015 | Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977543013 | Live attenuated Human alphaherpesvirus 3 immunization via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977544019 | Live attenuated Varicella-zoster immunisation via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977545018 | Live attenuated Varicella-zoster vaccination via subcutaneous route | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 3977548016 | Administration of vaccine product containing only live attenuated Human alphaherpesvirus 3 antigen via subcutaneous route (procedure) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | Is a | Administration of live attenuated Human alphaherpesvirus 3 vaccine | true | Inferred relationship | Some | ||
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | Method | Administration - action | true | Inferred relationship | Some | 1 | |
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | has Route of administration | Subcutaneous route | true | Inferred relationship | Some | 1 | |
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | Direct substance | Live attenuated Human alphaherpesvirus 3 only vaccine product | true | Inferred relationship | Some | 1 | |
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | Is a | Procedure on subcutaneous tissue | true | Inferred relationship | Some | ||
| Administration of live attenuated Human alphaherpesvirus 3 vaccine via subcutaneous route | Procedure site - Indirect | Subcutaneous tissue structure | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Procedure foundation reference set
FHIR